Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials

Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials

Prior malignancy exclusion criteria (PMEC) are often utilized in cancer clinical trials; however, the incidence of PMEC and the association of PMEC with trial participant age disparities remain poorly understood. This study aimed to identify age disparities in oncologic randomized clinical trials as...

Full description

Bibliographic Details
Main Authors: Roshal R. Patel, Rose Parisi, Vivek Verma, Ramez Kouzy, Joseph Abi Jaoude, Timothy A. Lin, Clifton David Fuller, Noam A. VanderWalde, Reshma Jagsi, Benjamin D. Smith, Beverly Ashleigh Guadagnolo, Charles R. Thomas, Ethan B. Ludmir
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
prior malignancy exclusion criteria
age disparities
phase III
cancer clinical trials
Online Access:https://www.mdpi.com/2072-6694/14/4/1048

Internet

https://www.mdpi.com/2072-6694/14/4/1048

Similar Items